Bio-Techne Unveils ProximityScope Assay for Automated Spatial Protein Interaction Analysis

Reuters
Oct 28, 2025
Bio-Techne Unveils ProximityScope Assay for Automated Spatial Protein Interaction Analysis

Bio-Techne Corporation has announced the launch of the ProximityScope™ assay, a new spatial solution designed for integration with the Leica Biosystems BOND RX staining platform. This breakthrough enables researchers to visualize functional protein-protein interactions within fixed tissue at subcellular resolution, and allows for the simultaneous detection of protein proximity, RNA, and proteins on the same tissue section. The automated multiomic workflow is set to be showcased at the upcoming Society for Immunotherapy of Cancer $(SITC)$ meeting on November 7-8 in Washington, DC. No specific research results were announced; rather, the company highlighted the capabilities and future presentation of the technology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG08289) on October 28, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10